Welcome to Mx’s (to be pronounced as emukk’s) Homepage

July 19th, 2023 is the third Anniversary of this homepage. Current main issues on Mx homepage are as follows. Basically, Mx is a research and development type business entity.

  • General biological phenomena related to Glycans and Lectins and those application to real life
  • Realization of sustainable and regenerative agriculture and food safety
  • Evanescent-field fluorescence excitation Glycan Profiler (GlycoStation®)
  • Biosensors for detecting microbes (Optic Biome Sensor)
  • Easy to use Statistical Analysis & Deep Learning Software (GlycoStation®SA/DL Easy)
  • R&D consumables (Culture media for MSC, Special Culture media, Lectin, etc.)
With and After Corona’s world will transform various social structures, including work styles. So, Let’s move forward with our life, breaking from the past. We are now developing a new business with the goal of contributing to human health and food safety in order to realize a sustainable society. (Cartoon Style)
from Japan to the World, Mx products, Glycan Profiler, Optic Biome Sensor, etc.

News (Carbohydrates related International Conferences)

Carbohydrates related International Conferences which will be held in overseas in 2024-2025 was summarized. (May 7th, 2024)

News(Updated Information about GlycoStation Related Products)

The most recent Information about GlycoStation related products (GSR22300, GSL-2200, and IgG1-mAb-LecChip) was uploaded for your information. Since some Video were embeded in this document, PowerPoint was used instead of pdf. (Feb. 1st, 2024)

FDA has published a paper on lectin microarrays for simple and rapid therapeutic mAbs. This result was also a joint study between FDA and GlycoTechnica. In this paper, Glycan Profiler GSR2300 and 14-well lectin microarrays using 9 kinds of carefully selected lectins were used. (Jan. 26th, 2024)

A Happy New Year.

Thank you very much for your help and support for our company during the past year. We look forward to continuing work with you in 2024.

We could successfully complete our first fiscal year, and achieved a surplus with debt-free management.

Previous news has been archived in the past news list.